Pediatric Hodgkin's survivors need to be vigilant

Findings by researchers from Stanford University Medical Center and published in the Journal of Clinical Oncology suggest that survivors of pediatric Hodgkin's lymphoma need to remain vigilant about their health even thirty years after their initial diagnosis.

Researchers examined 110 pediatric Hodgkin's lymphoma survivors between 1970 and 1990 who were treated with low-dose radiation and chemotherapy. During a median follow-up of 20.6 years, they found that 18 of those patients had developed at least one secondary cancer, ranging from leukemia to carcinomas of the breast or thyroid.

In sum, they found that the risk of secondary cancers for these patients at 20 years was 17 percent and at 30 years, nearly 30 percent.

By Ross Bonander

Source: Leukemia & Lymphoma Society

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...